Technical Analysis for VTGN - VistaGen Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 1.68 1.20% 0.02
VTGN closed up 1.2 percent on Friday, January 18, 2019, on 67 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical VTGN trend table...

Date Alert Name Type % Chg
Jan 18 Hammer Candlestick Bullish 0.00%
Jan 18 Pocket Pivot Bullish Swing Setup 0.00%
Jan 18 Doji - Bullish? Reversal 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 17 Wide Bands Range Expansion 1.20%
Jan 16 50 DMA Resistance Bearish -1.18%
Jan 16 Narrow Range Bar Range Contraction -1.18%
Jan 16 NR7 Range Contraction -1.18%
Jan 16 Inside Day Range Contraction -1.18%
Jan 16 Wide Bands Range Expansion -1.18%

Older signals for VTGN ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system (CNS). The company's lead product candidate, AV-101, is an orally available prodrug candidate in Phase II development, initially for the adjunctive treatment of major depressive disorder (MDD) in patients with an inadequate response to standard antidepressants. It also focuses on potential commercial applications of its human pluripotent stem cell (hPSC) technology platform, including drug rescue to develop proprietary new chemical entities (NCEs) for internal drug candidate pipeline; and regenerative medicine (RM) using blood, cartilage, heart, and liver cells derived from hPSC technology. The company is also involved in the development of CardioSafe 3D, an in vitro bioassay system for predicting potential cardiotoxicity of new chemical entities (NCEs), including drug rescue NCEs; and LiverSafe 3D, a bioassay system to predict potential liver toxicity of new drug candidates, including potential drug metabolism issues and adverse drug-drug interactions. It has strategic collaborations with University Health Network for hPSC technology research and development; Synterys, Inc. to design, produce, and analyze drug rescue NCEs; and Cato Research, Ltd. for regulatory expertise and clinical development support. The company also has cooperative research and development agreement with the U.S. National Institute of Mental Health for the Phase II clinical study of AV-101. VistaGen Therapeutics, Inc. was founded in 1998 and is headquartered in South San Francisco, California.
Is VTGN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 2.44
52 Week Low 0.81
Average Volume 149,286
200-Day Moving Average 1.462
50-Day Moving Average 1.6969
20-Day Moving Average 1.573
10-Day Moving Average 1.699
Average True Range 0.1149
ADX 17.65
+DI 19.607
-DI 20.9875
Chandelier Exit (Long, 3 ATRs ) 1.5053
Chandelier Exit (Short, 3 ATRs ) 1.6047
Upper Bollinger Band 1.8697
Lower Bollinger Band 1.2763
Percent B (%b) 0.68
BandWidth 37.724094
MACD Line 0.0174
MACD Signal Line -0.0026
MACD Histogram 0.02
Fundamentals Value
Market Cap 15.75 Million
Num Shares 9.38 Million
EPS -1.35
Price-to-Earnings (P/E) Ratio -1.24
Price-to-Sales 7.65
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.83
Resistance 3 (R3) 1.81 1.75 1.81
Resistance 2 (R2) 1.75 1.71 1.76 1.80
Resistance 1 (R1) 1.71 1.68 1.73 1.73 1.79
Pivot Point 1.65 1.65 1.66 1.66 1.65
Support 1 (S1) 1.61 1.61 1.63 1.63 1.57
Support 2 (S2) 1.55 1.58 1.56 1.56
Support 3 (S3) 1.51 1.55 1.56
Support 4 (S4) 1.53